Research / NVT / Fundamental state Inspectable configuration
State dimensions Filing 0001720635-23-000029 General Corporate
Debt relative to revenue 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
143.75% · OPTIONAL · VALID
Capex intensity 94th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.31% · OPTIONAL · VALID
Operating cash generation 33th Own-history percentile · N=18
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
9.37% · OPTIONAL · VALID
Share-count growth 88th Own-history percentile · N=16
Evidence method Yoy · gp.fundamentals.shares_outstanding
-0.41% · CORE · VALID
Revenue growth 56th Own-history percentile · N=16
Evidence method Yoy · gp.fundamentals.revenue
6.61% · CORE · VALID
Inventory pressure 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
49.49% · OPTIONAL · VALID
Gross margin 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
40.94% · CORE · VALID
Operating margin 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
16.76% · CORE · VALID
R&D intensity 85th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.25% · OPTIONAL · VALID
SBC intensity 67th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.77% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Sep 30, 2021 10/10 normalized Level 3 Dec 31, 2021 10/10 normalized Level 3 Mar 31, 2022 10/10 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 10/10 normalized Level 3 Mar 31, 2023 10/10 normalized Level 3 Jun 30, 2023 10/10 normalized Level 3 Sep 30, 2023 10/10 normalized Level 3 Dec 31, 2023 10/10 normalized Level 3 Mar 31, 2024 10/10 normalized Level 3 Jun 30, 2024 10/10 normalized Level 3 Sep 30, 2024 10/10 normalized Level 3 Dec 31, 2024 10/10 normalized Level 3 Mar 31, 2025 10/10 normalized Level 3 Jun 30, 2025 10/10 normalized Level 3 Sep 30, 2025 10/10 normalized Level 3 Dec 31, 2025 10/10 normalized Level 3 Mar 31, 2026 10/10 normalized Level 3 Jun 30, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 37.24%
Current 143.75%
Delta 106.51% Capex Intensity Increased
Previous 1.58%
Current 2.31%
Delta 0.73% Cash Generation Decreased
Previous 13.56%
Current 9.37%
Delta -4.19% Dilution Increased
Previous -0.44%
Current -0.41%
Delta 0.03% Growth Decreased
Previous 18.16%
Current 6.61%
Delta -11.55% Inventory Pressure Increased
Previous 11.92%
Current 49.49%
Delta 37.57% Margin Increased
Previous 37.70%
Current 40.94%
Delta 3.24% Profitability Increased
Previous 15.14%
Current 16.76%
Delta 1.62% R And D Intensity Increased
Previous 2.08%
Current 2.25%
Delta 0.18% Sbc Intensity Decreased
Previous 0.86%
Current 0.77%
Delta -0.09% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.